MedTrace Logo

Post-market Clinical Study to Confirm Safety and Performance of PuraStat® for the Management of Bleeding in Vascular Surgery.

NCT03103282 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 65

Last updated 2020-12-10

Study results available
· View outcomes & findings →

Summary

The objective of this post-market clinical follow-up study is to collect medical information on patients implanted with PuraStat®, according to each participating institution's procedures and standards of care.

Conditions

  • Vascular Anastomosis Surgery

Interventions

DEVICE

PuraStat®

Synthetic haemostatic material

Sponsors & Collaborators

  • 3-D Matrix Europe SAS

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-14
Primary Completion
2019-07-05
Completion
2019-08-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03103282 on ClinicalTrials.gov